Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.62
0.321.75%
At close: -
$18.85
0.231.24%
After Hours: 6:03 PM EDT
Comments
Loading...
Alignment Healthcare Analyst Ratings and Price Targets | NASDAQ:ALHC | Benzinga
Alignment Healthcare Inc has a consensus price target of $15.21 based on the ratings of 19 analysts. The high is $21 issued by Piper Sandler on March 4, 2025. The low is $7.25 issued by B of A Securities on November 2, 2023. The 3 most-recent analyst ratings were released by JP Morgan, Piper Sandler, and B of A Securities on March 6, 2025, March 4, 2025, and March 4, 2025, respectively. With an average price target of $18.83 between JP Morgan, Piper Sandler, and B of A Securities, there's an implied -0.09% downside for Alignment Healthcare Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Piper Sandler
B of A Securities
Stifel
Barclays
1calculated from analyst ratings
Analyst Ratings for Alignment Healthcare
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | Buy Now | -9.81% | JP Morgan | Lisa Gill60% | $14 → $17 | Maintains | Neutral | Get Alert |
| 03/04/2025 | Buy Now | 11.41% | Piper Sandler | Jessica Tassan40% | $14 → $21 | Maintains | Overweight | Get Alert |
| 03/04/2025 | Buy Now | -1.86% | B of A Securities | Adam Ron61% | $15.5 → $18.5 | Maintains | Buy | Get Alert |
| 02/28/2025 | Buy Now | -4.51% | Stifel | Craig Jones61% | $16 → $18 | Maintains | Buy | Get Alert |
| 02/28/2025 | Buy Now | -52.25% | Barclays | Andrew Mok55% | $8 → $9 | Maintains | Underweight | Get Alert |
| 02/24/2025 | Buy Now | -9.81% | Stephens & Co. | Raj Kumar 45% | $17 → $17 | Reiterates | Overweight → Overweight | Get Alert |
| 01/14/2025 | Buy Now | -15.12% | Stifel | Craig Jones61% | $14 → $16 | Maintains | Buy | Get Alert |
| 01/02/2025 | Buy Now | -9.81% | Stephens & Co. | Scott Fidel69% | $17 → $17 | Reiterates | Overweight → Overweight | Get Alert |
| 12/03/2024 | Buy Now | -9.81% | Stephens & Co. | Scott Fidel69% | $13 → $17 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/31/2024 | Buy Now | -31.03% | TD Cowen | Gary Taylor60% | $10 → $13 | Maintains | Buy | Get Alert |
| 10/30/2024 | Buy Now | -57.56% | Barclays | Andrew Mok55% | $7 → $8 | Maintains | Underweight | Get Alert |
| 10/30/2024 | Buy Now | -36.34% | UBS | Kevin Caliendo71% | $9 → $12 | Maintains | Neutral | Get Alert |
| 10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor66% | — | Initiates | → Sector Weight | Get Alert |
| 08/14/2024 | Buy Now | -41.64% | Baird | Michael Ha51% | $10 → $11 | Maintains | Outperform | Get Alert |
| 08/06/2024 | Buy Now | -46.95% | TD Cowen | Gary Taylor60% | $8 → $10 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | -46.95% | Piper Sandler | Jessica Tassan40% | $8 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 08/05/2024 | Buy Now | -62.86% | Barclays | Andrew Mok55% | $4.5 → $7 | Maintains | Underweight | Get Alert |
| 07/26/2024 | Buy Now | -36.34% | Stifel | Craig Jones61% | $9 → $12 | Maintains | Buy | Get Alert |
| 05/30/2024 | Buy Now | -46.95% | Baird | Michael Ha51% | → $10 | Initiates | → Outperform | Get Alert |
| 05/08/2024 | Buy Now | -57.56% | Piper Sandler | Jessica Tassan40% | $6 → $8 | Upgrade | Neutral → Overweight | Get Alert |
| 05/03/2024 | Buy Now | -62.86% | Stephens & Co. | Scott Fidel69% | $6 → $7 | Maintains | Equal-Weight | Get Alert |
| 04/23/2024 | Buy Now | -52.25% | Stifel | Craig Jones61% | $11 → $9 | Maintains | Buy | Get Alert |
| 03/06/2024 | Buy Now | -68.17% | Piper Sandler | Jessica Tassan40% | $12 → $6 | Downgrade | Overweight → Neutral | Get Alert |
| 03/06/2024 | Buy Now | -76.13% | Barclays | Andrew Mok55% | → $4.5 | Initiates | → Underweight | Get Alert |
| 02/28/2024 | Buy Now | -54.91% | UBS | Kevin Caliendo71% | $9 → $8.5 | Maintains | Neutral | Get Alert |
| 01/24/2024 | Buy Now | -41.64% | Stifel | Craig Jones61% | → $11 | Initiates | → Buy | Get Alert |
| 01/09/2024 | Buy Now | -36.34% | Raymond James | John Ransom75% | $10 → $12 | Maintains | Strong Buy | Get Alert |
| 01/09/2024 | Buy Now | -44.3% | Stephens & Co. | Scott Fidel69% | $10 → $10.5 | Maintains | Equal-Weight | Get Alert |
| 12/21/2023 | Buy Now | -52.25% | UBS | Kevin Caliendo71% | $6.5 → $9 | Maintains | Neutral | Get Alert |
| 11/02/2023 | Buy Now | -61.54% | B of A Securities | Kevin Fischbeck67% | → $7.25 | Downgrade | Buy → Neutral | Get Alert |
| 10/16/2023 | Buy Now | -46.95% | Raymond James | John Ransom75% | $9 → $10 | Upgrade | Outperform → Strong Buy | Get Alert |
| 10/12/2023 | Buy Now | -52.25% | Stephens & Co. | Scott Fidel69% | → $9 | Initiates | → Equal-Weight | Get Alert |
| 08/30/2023 | Buy Now | -36.34% | Morgan Stanley | Ricky Goldwasser78% | $19 → $12 | Maintains | Overweight | Get Alert |
| 07/14/2023 | Buy Now | 0.8% | Morgan Stanley | Ricky Goldwasser78% | $19 → $19 | Reiterates | Overweight → Overweight | Get Alert |
| 07/13/2023 | Buy Now | -68.17% | UBS | Kevin Caliendo71% | $8 → $6 | Maintains | Neutral | Get Alert |
| 07/07/2023 | Buy Now | -46.95% | JP Morgan | Lisa Gill60% | $12 → $10 | Maintains | Neutral | Get Alert |
| 05/01/2023 | Buy Now | -52.25% | Raymond James | John Ransom75% | → $9 | Upgrade | Market Perform → Outperform | Get Alert |
| 04/19/2023 | Buy Now | -36.34% | Goldman Sachs | Nathan Rich43% | $14 → $12 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | -25.73% | Goldman Sachs | Nathan Rich43% | $21 → $14 | Maintains | Buy | Get Alert |
| 03/03/2023 | Buy Now | -36.34% | Piper Sandler | Jessica Tassan40% | $19 → $12 | Maintains | Overweight | Get Alert |
| 03/02/2023 | Buy Now | -46.95% | TD Cowen | Gary Taylor60% | $17 → $10 | Maintains | Outperform | Get Alert |
| 02/23/2023 | Buy Now | -36.34% | JP Morgan | Lisa Gill60% | $22 → $12 | Downgrade | Overweight → Neutral | Get Alert |
| 11/21/2022 | Buy Now | — | Raymond James | John Ransom75% | — | Downgrade | Outperform → Market Perform | Get Alert |
| 08/22/2022 | Buy Now | -9.81% | Cowen & Co. | Gary Taylor60% | $12 → $17 | Maintains | Outperform | Get Alert |
| 08/10/2022 | Buy Now | 0.8% | Morgan Stanley | Ricky Goldwasser78% | $18 → $19 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | -9.81% | UBS | Kevin Caliendo71% | $11 → $17 | Maintains | Neutral | Get Alert |
| 08/08/2022 | Buy Now | 11.41% | Goldman Sachs | Nathan Rich43% | $14 → $21 | Maintains | Buy | Get Alert |
| 08/08/2022 | Buy Now | 11.41% | Barclays | Sarah James51% | $14 → $21 | Maintains | Overweight | Get Alert |
| 08/08/2022 | Buy Now | 16.71% | Raymond James | John Ransom75% | $20 → $22 | Maintains | Outperform | Get Alert |
| 08/05/2022 | Buy Now | 6.1% | Piper Sandler | Jeff Garro37% | $15 → $20 | Maintains | Overweight | Get Alert |
| 06/07/2022 | Buy Now | -4.51% | Morgan Stanley | Ricky Goldwasser78% | $21 → $18 | Maintains | Overweight | Get Alert |
| 05/26/2022 | Buy Now | -25.73% | B of A Securities | Kevin Fischbeck67% | $18 → $14 | Upgrade | Neutral → Buy | Get Alert |
| 05/12/2022 | Buy Now | -25.73% | Goldman Sachs | Nathan Rich43% | $16 → $14 | Maintains | Buy | Get Alert |
| 04/04/2022 | Buy Now | 0.8% | SVB Leerink | Whit Mayo68% | → $19 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Alignment Healthcare (ALHC) stock?
The latest price target for Alignment Healthcare (NASDAQ:ALHC) was reported by JP Morgan on March 6, 2025. The analyst firm set a price target for $17.00 expecting ALHC to fall to within 12 months (a possible -9.81% downside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Alignment Healthcare (ALHC)?
The latest analyst rating for Alignment Healthcare (NASDAQ:ALHC) was provided by JP Morgan, and Alignment Healthcare maintained their neutral rating.
When was the last upgrade for Alignment Healthcare (ALHC)?
The last upgrade for Alignment Healthcare Inc happened on December 3, 2024 when Stephens & Co. raised their price target to $17. Stephens & Co. previously had an equal-weight for Alignment Healthcare Inc.
When was the last downgrade for Alignment Healthcare (ALHC)?
The last downgrade for Alignment Healthcare Inc happened on March 6, 2024 when Piper Sandler changed their price target from $12 to $6 for Alignment Healthcare Inc.
When is the next analyst rating going to be posted or updated for Alignment Healthcare (ALHC)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alignment Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alignment Healthcare was filed on March 6, 2025 so you should expect the next rating to be made available sometime around March 6, 2026.
Is the Analyst Rating Alignment Healthcare (ALHC) correct?
While ratings are subjective and will change, the latest Alignment Healthcare (ALHC) rating was a maintained with a price target of $14.00 to $17.00. The current price Alignment Healthcare (ALHC) is trading at is $18.85, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.